---
title: "Naftopidil - Benign Prostatic Hyperplasia"
sidebar: mydoc_sidebar
permalink: db12092-mesh-d011470-1.html
toc: false 
---


Path ID: `DB12092_MESH_D011470_1`
{% include image.html url="images/db12092-mesh-d011470-1.png" file="db12092-mesh-d011470-1.png" alt="db12092-mesh-d011470-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C064357 | naftopidil | Drug |
| UniProt:P25100 | Alpha-1D adrenergic receptor | Protein |
| GO:0006939 | smooth muscle contraction | BiologicalProcess |
| HP:0011037 | Decreased urine output | PhenotypicFeature |
| MESH:D011470 | Benign prostatic hyperplasia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Naftopidil | DECREASES ACTIVITY OF | Alpha-1D Adrenergic Receptor |
| Alpha-1D Adrenergic Receptor | POSITIVELY REGULATES | Smooth Muscle Contraction |
| Smooth Muscle Contraction | POSITIVELY CORRELATED WITH | Decreased Urine Output |
| Decreased Urine Output | MANIFESTATION OF | Benign Prostatic Hyperplasia |
|---------|-----------|---------|

Reference: 
  - [https://en.wikipedia.org/wiki/Naftopidil](https://en.wikipedia.org/wiki/Naftopidil)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL142635/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL142635/)
  - [https://en.wikipedia.org/wiki/Alpha_blocker#Benign_prostatic_hyperplasia](https://en.wikipedia.org/wiki/Alpha_blocker#Benign_prostatic_hyperplasia)
  - [https://en.wikipedia.org/wiki/Benign_prostatic_hyperplasia](https://en.wikipedia.org/wiki/Benign_prostatic_hyperplasia)
